Skip to main content
Top
Published in: CNS Drugs 4/2005

01-04-2005 | Adis Drug Profile

Intranasal Sumatriptan in Adolescents with Migraine

A Viewpoint by Michael Christensen

Author: Michael Christensen

Published in: CNS Drugs | Issue 4/2005

Login to get access

Excerpt

Sumatriptan belongs to a class of agents that are serotonin 5-HT1 agonists, which are thought to exert their effects by constricting cranial blood vessels and inhibiting the release of inflammatory mediators. Sumatriptan was the first of a number of drugs in this class that are available for the treatment of migraine. It is available as an injectable for subcutaneous administration, an oral tablet, a suppository for rectal administration and as a nasal spray. The different dosage forms allow sumatriptan administration to be adapted to patient preference. …
Metadata
Title
Intranasal Sumatriptan in Adolescents with Migraine
A Viewpoint by Michael Christensen
Author
Michael Christensen
Publication date
01-04-2005
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 4/2005
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-200519040-00008

Other articles of this Issue 4/2005

CNS Drugs 4/2005 Go to the issue

Adis Drug Profile

Intranasal Sumatriptan

Adis Drug Evaluation

Zonisamide